Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by AmorFatiforlifeon Mar 17, 2021 10:13am
142 Views
Post# 32815672

RE:35 shares

RE:35 sharesAnother oddity that we can add to the growing list. The book would be a best seller "The trials and tribulations of the EDT investor" the epic tale of the hero to zero to hero once more. Should be around the corner that we see financials and some guidance from out newly appointed CSuite. One would also assume that we should start to hear some rumbling from our new marketing team from down south??? Shouldn't really take much to market a company that has ten times more clout than some of the biotech companys that are trading at 20x EV. Not long now guys.. feeling its just around the corner...and perhaps around the bend. Regards
<< Previous
Bullboard Posts
Next >>